Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14601 - 14625 of 14686 in total
SB-224289 is a small molecule with a high affinity for human 5-HT1B receptors.
Investigational
Matched Salts name: … SB 224289 hydrochloride
RS-39604 is a selective 5-HT4 receptor antagonist.
Investigational
Matched Salts name: … RS-39604 hydrochloride
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational
Matched Salts name: … BMS-863233 hydrochloride
PHA-767491 is a Cdc7/CDK9 inhibitor.
Investigational
Matched Salts name: … PHA-767491 hydrochloride
Henatinib has been used in trials studying the treatment of Advanced Solid Cancer.
Investigational
SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist of the serotonin receptor 7 (5-HT7).[A31816,A31817]
Investigational
Matched Salts name: … SB-269970 hydrochloride
PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).
Investigational
An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of the host...
Investigational
Matched Description: … To create ACA-125, a hybridoma cell was adapted to serum-free medium and antibody was produced in a hollow …
Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
Experimental
Investigational
Matched Categories: … Cannabinoids and similars …
Investigational
Matched Salts name: … Fostroxacitabine bralpamide hydrochloride
Investigational
Experimental
PRLX 93936 is selectively toxic to cancer cells.
Investigational
Displaying drugs 14601 - 14625 of 14686 in total